[en] T70N human lysozyme is the only known naturally occurring destabilised lysozyme variant that has not been detected in amyloid deposits in human patients. Its study and a comparison of its properties with those of the amyloidogenic variants of lysozyme is therefore important for understanding the determinants of amyloid disease. We report here the X-ray crystal structure and the solution dynamics of T70N lysozyme, as monitored by hydrogen/deuterium exchange and NMR relaxation experiments. The X-ray crystal structure shows that a substantial structural rearrangement results from the amino acid substitution, involving residues 45–51 and 68–75 in particular, and gives rise to a concomitant separation of these two loops of up to 6.5 Å. A marked decrease in the magnitudes of the generalised order parameter (S2) values of the amide nitrogen atom, for residues 70–74, shows that the T70N substitution increases the flexibility of the peptide backbone around the site of mutation. Hydrogen/deuterium exchange protection factors measured by NMR spectroscopy were calculated for the T70N variant and the wild-type protein. The protection factors for many of backbone amide groups in the β-domain of the T70N variant are decreased relative to those in the wild-type protein, whereas those in the α-domain display wild-type-like values. In pulse-labelled hydrogen/deuterium exchange experiments monitored by mass spectrometry, transient but locally cooperative unfolding of the β-domain of the T70N variant and the wild-type protein was observed, but at higher temperatures than for the amyloidogenic variants I56T and D67H. These findings reveal that such partial unfolding is an intrinsic property of the human lysozyme structure, and suggest that the readiness with which it occurs is a critical feature determining whether or not amyloid deposition occurs in vivo.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Johnson, Russell J.K.
Christodoulou, John
Dumoulin, Mireille ; Université de Liège - ULiège > Département des sciences de la vie > Enzymologie et repliement des protéines
Caddy, Gemma L.
Alcocer, Marcos J.C.
Murtagh, Gareth J.
Kumita, Janet
Larsson, Göran
Robinson, Carol V.
Archer, David B.
Luisi, Ben
Dobson, Christopher M.
Language :
English
Title :
Rationalising Lysozyme Amyloidosis: Insights from the Structure and Solution Dynamics of T70N Lysozyme
M.B. Pepys, P.N. Hawkins, D.R. Booth, D.M. Vigushin, G.A. Tennent, and A.K. Soutar Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 362 1993 553 557
M. Yazaki, S.A. Farrell, and M.D. Benson A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis Kidney Int. 63 2003 1652 1657
S. Valleix, S. Drunat, J. Philit, D. Adoue, J. Piette, and D. Droz Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family Kidney Int. 61 2002 907 912
P.J. Artymiuk, and C.C.F. Blake Refinement of human lysozyme at 1.5 Å resolution. Analysis of non bonded and hydrogen bonded interactions J. Mol. Biol. 152 1981 737 762
D.R. Booth, M.B. Pepys, and P.N. Hawkins A novel variant of human lysozyme (T70N) is common in the normal population Hum. Mutat. 16 2000 180 181
G. Esposito, J. Garcia, P. Mangione, S. Giorgetti, A. Corazza, and P. Viglino Structural and folding dynamic properties of the T70N variant of human lysozyme J. Biol. Chem. 278 2003 25910 25918
M. Dumoulin, A.M. Last, A. Desmyter, K. Decanniere, D. Canet, and G. Larsson A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 2003 783 788
M. Dumoulin, D. Canet, A.M. Last, D.B. Archer, S. Muyldermans, and L. Wyns Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations J. Mol. Biol. 346 2005 773 788
J.D. Harper, and P.T. Lansbury Jr Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem 66 1997 385 407
T.R. Serio, A.G. Cashikar, A.S. Kowal, G.J. Sawicki, J.J. Moslehi, and L. Serpell Nucleated conformational conversion and the replication of conformational information by a prion determinant Science 289 2000 1317 1321
D. Thirumalai, D.K. Klimov, and R.I. Dima Emerging ideas on the molecular basis of protein and peptide aggregation Curr. Opin. Struct. Biol. 13 2003 146 159
D. Canet, A.M. Last, P. Tito, M. Sunde, A. Spenser, and D.B. Archer Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme Nature Struct. Biol. 9 2002 308 315
D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
L.A. Morozova-Roche, J. Zurdo, A. Spenser, W. Noppe, V. Receveur, and D.B. Archer Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants J. Struct. Biol. 130 2000 339 351
A.K. Chamberlain, V. Receveur, A. Spencer, C. Redfield, and C.M. Dobson Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy Protein Sci. 10 2001 2525 2530
Y. Bai, J.S. Milne, L. Mayne, and S.W. Englander Primary structure effects on peptide group hydrogen exchange Proteins: Struct. Funct. Genet. 17 1993 75 86
S. Mine, T. Udea, Y. Hashimoto, and T. Imoto Analysis of the internal motion of free and ligand-bound human lysozyme by use of 15N NMR relaxation measurement: a comparison with those of hen lysozyme Protein Sci. 9 2000 1669 1684
G. Lipari, and A. Szabo Modelfree approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity J. Am. Chem. Soc. 104 1982 4546 4559
G. Lipari, and A. Szabo Modelfree approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results J. Am. Chem. Soc. 104 1982 4559 4570
G.M. Clore, A. Szabo, A. Bax, L.E. Kay, P.C. Driscoll, and A.M. Gronenborn Deviations from the simple two-parameter model-free approach to the interpretation of nitrogen-15 nuclear magnetic relaxation of proteins J. Am. Chem. Soc. 112 1990 4989 4991
A.M. Mandel, M. Akke, and A.G. Palmer III Backbone dynamics of Escherichia coli ribonuclease HI: correlations with structure and function in an active enzyme J. Mol. Biol. 246 1995 144 161
L.S. Itzhaki, D.E. Otzen, and A.R. Fersht The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding J. Mol. Biol. 254 1995 260 288
D.E. Otzen, L.S. Itzhaki, N.F. elMasry, S.E. Jackson, and A.R. Fersht Structure of the transition state for the folding/unfolding of the barley chymotrypsin inhibitor 2 and its implications for mechanisms of protein folding Proc. Natl Acad. Sci. USA 91 1994 10422 10425
P. Westermark, K. Sletten, B. Johansson, and G.G. Cornwell III Fibril in senile systemic amyloidosis is derived from normal transthyretin Proc. Natl Acad. Sci. USA 87 1990 2843 2845
M.B. Pepys Pathogenesis, diagnosis and treatment of systemic amyloidosis Phil. Trans. Roy. Soc. ser. B 356 2001 203 211
Z. Chen, and D.E. Ruffner Amplification of closed circular DNA in vitro Nucl. Acids Res. 26 2002 1126 1127
Y.C. Lee, and D. Yang Determination of lysozyme activities in a microplate format Anal. Biochem. 310 2002 223 224
A. Spencer, L.A. Morozova-Roche, W. Noppe, D.A. MacKenzie, D.J. Jeenes, and M. Joniau Expression, purification, and chracterisation of the recombinant calcium binding equine lysozyme secreted by the filamentous fungus, Aspergillus niger. Comparisons with the production of hen and human lysozymes Protein Expr. Purif. 16 1999 171 180
Z. Otwinoski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallog. sect. A 50 1994 157 163
A.T. Brünger, P.D. Adams, G. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography & NMR system: a new software suite for macromolecular structure determination Acta Crystallog. sect. D 54 1998 905 921
G.N. Murshudov, A.A. Vagin, and E.J. Dodson Refinement of macromolecular structures by the maximum-likelihood method Acta Crystallog. sect. D 53 1997 240 255
R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Crystallog. 26 1993 283 291
DePristo, M. A., de Bakker, P. I. W., Johnson, R. J. K. & Blundell, T. L. (2005). Crystallographic refinement by knowledge-based exploration of complex energy landscapes. Structure. In the press.
T. Ohkubo, Y. Taniyama, and M. Kikuchi 1H and 15N NMR study of human lysozyme J. Biochem. (Tokyo) 110 1991 1022 1029
F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, and A. Bax NMRPipe: a multidimensional spectral processing system based on UNIX pipes J. Biomol. NMR 6 1995 277 293
B.A. Johnson, and R.A. Blevins NMRView: a computer program for the visualization and analysis of NMR data J. Biol. NMR 4 1994 603
R. Koradi, M. Billeter, and K. Wüthrich MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graph. 14 1996 51 55